Area of research
Cancer Research · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Cancer Genomics and Diagnostics, HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, and Gene expression and cancer classification.
Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response
Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)
Abstract P4-07-01: Tumor expression and microenvironment in HER2-positive breast cancer before and on HER2-targeted therapy: Analysis of microarray expression data from the TRIO-US B07 trial
Clonal replacement of tumor-specific T cells following PD-1 blockade
Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy
Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy
Abstract P3-06-01: Clonal evolution and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy